Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

CFS Managed Investment Fund - Global Health & Biotechnology

+ Add to Watchlist

COLFHLB:AU

2.18 AUD -0.00-0.11%

As of 00:59:30 ET on 05/21/2015.

Snapshot for CFS Managed Investment Fund - Global Health & Biotechnology (COLFHLB)

Year To Date: +17.76% 3-Month: +5.80% 3-Year: +41.84% 52-Week Range: 1.38 - 2.23
1-Month: +0.08% 1-Year: +61.10% 5-Year: +24.95% Beta vs AS51: 0.60

Mutual Fund Chart for COLFHLB

No chart data available.
  • COLFHLB:AU 2.18
  • 1M
  • 1Y
Interactive COLFHLB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for COLFHLB

Colonial First State Mangaged Investment Funds - Global Health & Biotechnology Fund is a unit trust incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.

Inception Date: 04-28-2000 Telephone: Tel: 61-2-9303-3000
Managers: DAVID L LEARY
Web Site: www.colonialfirststate.com.au

Fundamentals for COLFHLB

NAV (on 2015-05-21) 2.18
Assets (M) (on 2015-02-27) 26.30
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for COLFHLB

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for COLFHLB

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 2.05
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for COLFHLB

Filing Date: 02/28/2015
Name Position Value % of Total
Medtronic PLC 17,164 1,698,921 6.460%
Bristol-Myers Squibb Co 20,443 1,585,835 6.030%
Actavis plc 3,904 1,456,970 5.540%
Gilead Sciences Inc 10,135 1,343,883 5.110%
McKesson Corp 3,412 999,365 3.800%
UnitedHealth Group Inc 6,437 933,618 3.550%
Regeneron Pharmaceuticals Inc 1,628 862,610 3.280%
Aetna Inc 6,037 767,933 2.920%
Alkermes PLC 8,038 723,225 2.750%
HCA Holdings Inc 6,745 618,029 2.350%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil